Patent · US Active

Sustained release formulations of Crocus sativus

US12023365B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH · IN

Inventors

Sonali Sandip Bharate · Jammu, IN
Vikas Kumar · Jammu, IN
Rohit Singh · Jersey City, US
Sarita Rani · Jammu, IN
Mehak Gupta · Jammu, IN
Ajay Kumar · Fairport, US
Sandip Bibishan Bharate · Ranbir Singh Pura, IN
Ram Vishwakarma · Jammu, IN

Key dates

Filing date	Oct 18, 2018
Grant date	Jul 2, 2024
Priority date	—
Expiry date	Aug 18, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2236/333
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to the novel oral dosage form for sustained release of crocin-1, a active constituent of Crocus sativus extract or fraction and a process for preparing the same wherein the extract is wet-granulated using excipients, biodegradable polymers and/or non-biodegradable polymers alone or in combination. The said formulations are useful for the treatment of chronic inflammatory diseases wherein NLRP3 inflammasome is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.